The Rare Movement Disorders Research Group


Banniere LinkedIn2500
© D. AKTAN

Rare Movement Disorders (RMD)

Research Group

Photo d'identité FDEPIERREUX 72dpi
© DEPIERREUX
charlotte
© C. MOURAUX
Aktan David
© D. AKTAN

Frédérique DEPIERREUX

MD, PhD    

 Charlotte MOURAUX  

 MD

  David AKTAN  

MD

                              

The Rare Movement Disorders (RMD) Research Group is a multidisciplinary team of neurologists, geneticists, neuroscientists, and neuroimaging specialists. We are dedicated to advancing the diagnosis and treatment of rare movement disorders, particularly those of genetic origin.

These disorders—such as dystonia, chorea, paroxysmal movement disorders, and metabolic movement disorders—affect individuals of all ages. Due to their complexity and rarity, patients often face long diagnostic delays and uncertainty.

Our Mission

Our core mission is to develop and validate innovative diagnostic strategies using:

- Genetic testing (including next-generation sequencing),

- Advanced brain imaging (such as ultra-high field MRI),

- And novel biomarkers.

By refining these techniques, we aim to reduce diagnostic delays and guide patients toward targeted, evidence-based treatments.

 

RMD Presentation

© D. AKTAN


Current Research Projects

1. MDWGS Study

Leads: Prof. F. Depierreux & Dr. C. Mouraux
Started: 2022
Focus: Genetic Diagnosis of Movement Disorders

RMD Genetics2500

© C. MOURAUX

The MDWGS (Movement Disorders Whole Genome Sequencing) study is a prospective, monocentric observational study designed to improve the diagnosis of rare but potentially treatable movement disorders. The research compares the effectiveness and cost-efficiency of:

- Targeted Next-Generation Sequencing (NGS) panels,

- Whole Exome Sequencing (WES),

- Whole Genome Sequencing (WGS),

- Deep sequencing for detecting copy number variations (CNVs).

Participants include deeply phenotyped patients with undiagnosed hypokinetic or hyperkinetic movement disorders, recruited from the Neurology Department of CHU Liège. The ultimate goal is to accelerate diagnosis and improve enrollment in clinical trials for novel therapies.

vid-img-1
Youtube


2. FocalDys Study

Leads: Prof. F. Depierreux & Dr. D. Aktan
Focus: Diagnostic Tools for Focal Dystonia

RMD Imaging2500

© D. AKTAN

 

The FocalDys study focuses on a specific form of movement disorder—focal dystonia. It aims to evaluate and compare three diagnostic approaches:

- 7-Tesla Ultra-High Field MRI,

- Transcranial ultrasound,

- Genetic analysis (via MDWGS protocols).

This research is designed to establish a standard diagnostic workflow for focal dystonia and guide patients toward effective second-line therapies such as botulinum toxin injections or deep brain stimulation (DBS).

 

RMD banner2500

© D. AKTAN

You might also be interested in :

our projects

Our clinical unit

Our Rare DisEase Centre

A video presentation of our projects (in French) 

a more historical and artistic perspective (also in French)

updated on 10/3/25

Share this page

cookieImage